Efficacy Evaluation of a Novel Home-Used Device Based on Multiple Stimulation Technology on Hair Growth in Patients with Androgenetic Alopecia
August 2018
in “
Madridge journal of dermatology & research
”
Studysummary This study observed that the Pilogics Hairegen device increased total hair count by 23.2% and terminal hair count by 21.1% in 289 patients with androgenetic alopecia after approximately 20 weeks of use, with no adverse effects reported.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on madridge.org →